跳至主要内容
临床试验/NCT04437745
NCT04437745已完成不适用

A Multicenter, Randomized, Rater-Blinded, No-Treatment Control Design Clinical Study to Evaluate the Effectiveness and Safety of YVOIRE Y-Solution 720 Injected Into the Mid-Face

LG Chem1 个研究点 分布在 1 个国家目标入组 238 人开始时间: 2020年11月25日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
238
试验地点
1
主要终点
Asian Faces Mid-Face Volume Deficit Severity Rating Scale (MFVDA-SRS) responder rate

研究概览

简要总结

To Evaluate the Effectiveness and Safety of YVOIRE Y-Solution 720 Injected Into the Mid-Face

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Outcomes Assessor)

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Male or female adults 18 to 65 years of age (inclusive)
  • 3 (moderate) or 4 (severe) on MFVDA-SRS
  • sign the written informed consent form

排除标准

  • have streptococcal disease or bleeding disorder
  • have an active or infective skin disease, scars, or tumor on mid-face
  • have congenital defect, trauma, abnormalities in adipose tissue related to immune-mediated diseases
  • have undergone facial plastic surgery, tissue grafting, or tissue augmentation with silicone, fat, or other permanent, or semi-permanent procedures/treatment
  • have undergone temporary facial dermal filler within 12 months, porcine-based collagen fillers within 24 months, or neuromodulator injections, mesotherapy, or resurfacing within 6 months
  • have a medical history of hypertrophic cicatrix or keloid
  • have radiation therapy experience on mid-face
  • have a history of anaphylaxis, multiple severe allergies, atopy, or allergy to lidocaine, hyaluronic acid products, or Streptococcal protein

结局指标

主要结局

Asian Faces Mid-Face Volume Deficit Severity Rating Scale (MFVDA-SRS) responder rate

时间窗: 26 weeks from baseline

the proportion of subjects with ≥1-grade reduction on the MFVDA-SRS score (The MFVDA-SRS score ranges from 1-4 with higher score indicating increasing severity of mid-face volume deficit.)

次要结局

未报告次要终点

研究者

发起方
LG Chem
申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

To Evaluate the Effectiveness and Safety of YVOIRE... | 临床试验